EXAGEN INC. Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net
EXAGEN INC. (XGN) had Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net of $3.03 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes
us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet · last filed 2026-08-04
- 2026-06-30: Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net $3.03M.
- 2026-03-31: Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net $3.17M.
- 2025-12-31: Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net $3.30M.
- 2025-09-30: Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net $3.43M.
| Period end | Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net |
|---|---|
| 2026-06-30 | $3.03M 10-Q · filed 2026-08-04 |
| 2026-03-31 | $3.17M 10-Q · filed 2026-05-11 |
| 2025-12-31 | $3.30M 10-K · filed 2026-03-10 |
| 2025-09-30 | $3.43M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $3.56M 10-Q · filed 2025-07-29 |
| 2025-03-31 | $60.00K 10-Q · filed 2025-05-05 |
| 2024-12-31 | $70.00K 10-K · filed 2025-03-11 |
| 2024-09-30 | $80.00K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $93.00K 10-Q · filed 2024-08-05 |
| 2024-03-31 | $103.00K 10-Q · filed 2024-05-13 |
| 2023-12-31 | $113.00K 10-K · filed 2024-03-18 |
| 2023-09-30 | $124.00K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $134.00K 10-Q · filed 2023-08-07 |
| 2023-03-31 | $145.00K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $158.00K 10-K · filed 2023-03-20 |
| 2022-09-30 | $170.00K 10-Q · filed 2022-11-21 |
| 2022-06-30 | $182.00K 10-Q/A · filed 2022-11-21 |
| 2022-03-31 | $195.00K 10-Q · filed 2022-05-11 |
| 2021-12-31 | $208.00K 10-K · filed 2022-03-22 |
| 2021-09-30 | $224.00K 10-Q · filed 2021-11-10 |
| 2021-06-30 | $249.00K 10-Q · filed 2021-08-09 |
| 2021-03-31 | $273.00K 10-Q · filed 2021-05-11 |
| 2020-12-31 | $296.00K 10-K · filed 2021-03-16 |
| 2020-09-30 | $320.00K 10-Q · filed 2020-11-10 |
| 2020-06-30 | $344.00K 10-Q · filed 2020-07-28 |
| 2020-03-31 | $367.00K 10-Q · filed 2020-05-11 |
| 2019-12-31 | $390.00K 10-K · filed 2020-03-25 |
| 2019-09-30 | $484.00K 10-Q · filed 2019-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |